Moreover, inhibiting MMP-3 is emerging as a promising therapeutic approach for conditions such as COVID-19-associated acute respiratory distress syndrome (ARDS) [45], reflecting functions that extend beyond extracellular proteolysis to include the modulation of immune responses [44]. The gene discussed is MMP3; the disease is acute respiratory distress syndrome.